Insights from the Oxford Nanopore Sydney User Group The shift from scientific capability to clinical reality requires a community that leans in. We recently had the privilege of exploring this at the Oxford Nanopore Technologies (ONT) Sydney User Group Meeting, held...
Why Infrastructure and Industry Collaboration are Key to Australia’s Genomic Future We are living in a transformative moment for healthcare. As InGeNA CEO Dr Erin Evans recently highlighted in the Herald Sun, we are moving away from a general approach and...
Advancing Cell & Gene Therapies Together: Thank You from the Summit Precision medicine is no longer just a scientific capability; it is a systemic challenge that requires us to work at pace. We recently had the privilege of exploring this at the Cell & Gene...
Reflecting on Rare Disease Day This year’s global Rare Disease Day theme is “More than you can imagine,” and we are deeply grateful to have seen this vision brought to life at the recent GSNV Rare Disease Day event. We were honored to join leading patient advocates...
For generations, the journey to parenthood has been described as a “miracle”, a roll of the biological dice. But as we settle into 2026, the narrative is shifting. We are moving away from a reliance on chance and towards the empowerment of choice. At InGeNA, we...
